REAL-WORLD HEALTH OUTCOMES, ECONOMIC IMPACTS, AND COST EFFECTIVENESS ASSOCIATED WITH INFLIXIMAB FOR RHEUMATOID ARTHRITIS IN A MEDIUM-SIZED CITY OF CHINA
Abstract
Authors
J. Li Z. Wen F. Tian L. Zhang Y. Luo L. Deng J. He Y. Yang Y. Chen H. Zhan W. Chen